Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Dian Diagnostics Group Co.,Ltd.
  6. News
  7. Summary
    300244   CNE1000015N1

DIAN DIAGNOSTICS GROUP CO.,LTD.

(300244)
  Report
End-of-day quote Shenzhen Stock Exchange  -  05-18
32.37 CNY   +0.68%
04/26Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/18Dian Diagnostics Group Co.,Ltd. Proposes Final Cash Dividend for 2021
CI
04/15Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Dian Diagnostics Group Co.,Ltd. Approved Final Cash Dividend for 2020

05/24/2021 | 03:43pm EDT
share with twitter
share with LinkedIn
share with facebook

Dian Diagnostics Group Co.,Ltd. at its Annual General Meeting of 2020 on 21 May 2021, approved final cash dividend of CNY 1.30000000 per 10 shares (tax included) for 2020.


© S&P Capital IQ 2021
All news about DIAN DIAGNOSTICS GROUP CO.,LTD.
04/26Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended Ma..
CI
04/18Dian Diagnostics Group Co.,Ltd. Proposes Final Cash Dividend for 2021
CI
04/15Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
02/21Asian Games Hangzhou appoints official health testing services supplier
AQ
2021Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended Sept..
CI
2021Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 3..
CI
2021Dian Diagnostics Group Co.,Ltd. Announces 2020 Final Profit Distribution Plan to Be Imp..
CI
2021Dian Diagnostics Group Co.,Ltd. Approved Final Cash Dividend for 2020
CI
2021Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended Ma..
CI
2021Dian Diagnostics Group Co.,Ltd. Proposes Final Cash Dividend for 2020
CI
More news
Financials
Sales 2022 16 556 M 2 467 M 2 467 M
Net income 2022 1 841 M 274 M 274 M
Net Debt 2022 18,7 M 2,79 M 2,79 M
P/E ratio 2022 10,9x
Yield 2022 1,19%
Capitalization 20 084 M 2 992 M 2 992 M
EV / Sales 2022 1,21x
EV / Sales 2023 1,05x
Nbr of Employees 11 123
Free-Float 35,4%
Chart DIAN DIAGNOSTICS GROUP CO.,LTD.
Duration : Period :
Dian Diagnostics Group Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIAN DIAGNOSTICS GROUP CO.,LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 32,37 CNY
Average target price 51,25 CNY
Spread / Average Target 58,3%
EPS Revisions
Managers and Directors
Bai Xing Huang Managing Director & Director
Fatt Heng Wong Chief Executive Officer
Yu Peng Shi Chief Financial Officer
Hai Bin Chen Chairman
Xiu Li Cheng Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
DIAN DIAGNOSTICS GROUP CO.,LTD.-3.57%2 992
CVS HEALTH CORPORATION-9.71%122 135
HCA HEALTHCARE, INC.-20.94%60 022
LABORATORY CORPORATION OF AMERICA HOLDINGS-21.57%22 844
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY34.45%20 246
FRESENIUS MEDICAL CARE AG & CO. KGAA-2.31%17 318